Drug Selection for Intrathecal Drug Delivery


Agent

Starting dose

Morphine

0.1–0.5 mg/day

Hydromorphone

0.02–0.5 mg/day

Fentanyl

25–75 μg/day

Bupivacaine

1–4 mg/day

Clonidine

40–100 μg/day

Ziconotide

0.5–2.4 μg/day


From Deer et al. (2012) with permission




Table 41.2
Polyanalgesic Consensus Conference 2012 recommendations for maximum concentration of intrathecal agents




























Agent

Maximum concentration

Morphine

20 mg/mL

Hydromorphone

15 mg/mL

Fentanyl

10,000 μg/mL

Bupivacaine

30 mg/mL

Clonidine

1000 μg/mL

Ziconotide

100 μg/mL


From Deer et al. (2012) with permission



Table 41.3
Polyanalgesic Consensus Conference 2012 recommendations for maximum dose of intrathecal agents




























Agent

Maximum dose

Morphine

15 mg/day

Hydromorphone

10 mg/day

Fentanyl

None

Bupivacaine

10 mg/day

Clonidine

600 μg/day

Ziconotide

19.2 μg/day


From Deer et al. (2012) with permission



Table 41.4
Polyanalgesic Consensus Conference 2012 recommendations for neuropathic pain

































Line 1

Morphine

Ziconotide
 
Morphine + bupivacaine

Line 2

Hydromorphone

Hydromorphone + bupivacaine or Hydromorphone + clonidine

Morphine + clonidine

Line 3

Clonidine

Ziconotide + opioid

Fentanyl

Fentanyl + bupivacaine or Fentanyl + clonidine

Line 4

Opioid + clonidine + bupivacaine

Bupivacaine + clonidine

Line 5

Baclofen


From Deer et al. (2012) with permission

Line 1: Morphine and ziconotide are approved by the US Food and Drug Administration for IT therapy and are recommended as first-line therapy for neuropathic pain. The combination of morphine and bupivacaine is recommended for neuropathic pain on the basis of clinical use and apparent safety. Line 2: Hydromorphone, alone or in combination with bupivacaine or clonidine, is recommended. Alternatively, the combination of morphine and clonidine may be used. Line 3: Third-line recommendations for neuropathic pain include clonidine, ziconotide plus an opioid, and fentanyl alone or in combination with bupivacaine or clonidine. Line 4: The combination of bupivacaine and clonidine (with or without an opioid drug) is recommended. Line 5: Baclofen is recommended on the basis of safety, although reports of efficacy are limited

Oct 16, 2016 | Posted by in PAIN MEDICINE | Comments Off on Drug Selection for Intrathecal Drug Delivery

Full access? Get Clinical Tree

Get Clinical Tree app for offline access